Skip to content
MedsAcross

Brand family

Letairis

Ambrisentan · Gilead Sciences
United States
Presentations
2
Markets
1

Letairis is a brand of Ambrisentan marketed by Gilead Sciences, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Ambrisentan
Brand owner
Gilead Sciences
Registered in
United States
Strengths and forms
10 mg tablet, 5 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Letairis 10 mg tabletOralGilead SciencesUS FDAAvailable on request
Letairis 5 mg tabletOralGilead SciencesUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Letairis

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.